NASDAQ$DCTH

Delcath Systems Inc · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Briefing

Delcath reported preliminary financial results for Q1 2023 and provided a business update.

Delcath Systems reported preliminary Q1 2023 revenue of $0.6 million, compared to $0.4 million in Q1 2022. The company had cash, cash equivalents, and restricted cash totaling $24.3 million as of March 31, 2023, compared to $11.8 million as of March 31, 2022. They are awaiting the FDA's decision on Hepzato Kit with a PDUFA date of August 14, 2023.

  • Received FDA acknowledgement of Class 2 NDA resubmission for Hepzato Kit with a PDUFA goal date of August 14, 2023.
  • Completed a private placement of up to $85 million in gross proceeds, including $25 million upfront.
  • Amended loan agreement to defer $4.3 million in principal payments.
  • Appointed John R. Sylvester as Chairman of the Board.

Headline financials

Total Revenue

$597K

Previous: $378K+57.9%
EPS (adj)

-$0.77

Previous: -$1.00+23.0%
Capital Expenditures

$0.00

Previous: $89K-100.0%
Free Cash Flow

-$9M

Previous: -$6.46M-39.2%
Net Income

-$9M

Previous: -$8.2M-9.8%
Operating Income

-$8.33M

Previous: -$7.54M-10.4%
Gross Profit

$416K

Previous: $345K+20.6%
Cash & Equivalents

$24.2M

Previous: $16.3M+48.2%
Total Assets

$30.6M

Previous: $27.3M+12.0%

Revenue & EPS history

Delcath · Revenue · Quarterly

$597K

Q1 2023+57.9%vs Q1 2022
Beat estimate in 6 of 15 quarters(40%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

-2.1%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+7.7%

Avg return

30 days after

28%

9 / 32 earnings

Positive

+37.5%

Q2 2019

Best reaction

-26.4%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.3%+0.6%-5.3%
Q4 2025-11.7%-15.8%-12.1%
Q3 2025-4.7%-9.2%+5.3%
Q1 2025+23.6%+31.7%+41.1%
Q4 2024-1.6%-12.1%-18.0%
Q3 2024-9.0%-14.0%+8.5%
Q2 2024-2.6%-4.2%+33.7%
Q1 2024+33.1%+40.2%+37.4%
Q4 2023+9.2%+2.4%+12.9%
Q3 2023-23.7%-16.9%+10.0%
Q2 2023-20.6%-23.3%+18.2%
Q1 2023+0.2%+7.8%+14.9%
Q4 2022+22.3%+18.8%+17.6%
Q3 2022-6.7%+0.0%+11.3%
Q2 2022-2.3%+10.2%-5.4%
Q1 2022-11.9%-16.7%-28.1%
Q4 2021+1.3%+2.8%+0.0%
Q3 2021-1.8%-5.0%-28.1%
Q2 2021-11.8%-13.5%+1.1%
Q1 2021-7.0%-0.6%+9.8%
Q4 2020-24.8%-7.2%-31.8%
Q3 2020+0.6%+3.6%+36.7%
Q2 2020-2.6%-4.6%-9.3%
Q1 2020-5.2%-5.2%+0.5%
Q4 2019+0.0%+13.8%+55.7%
Q3 2019-4.3%-4.3%-15.2%
Q2 2019+37.5%+27.5%+26.2%
Q1 2019-11.2%+0.0%+22.5%
Q4 2018-6.5%-8.9%-35.5%
Q3 2018-26.4%-0.3%-5.6%
Q2 2018+0.0%+19.0%+78.8%
Q1 2018+2.4%+0.3%-0.6%
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q3 2010
Q2 2010
Q1 2010

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro